Florida Poly assistant professor receives Fulbright to continue research in Canada
Chris Kelley, an assistant professor at Florida Polytechnic University in Lakeland, has been selected by the U.S. State Department as a Fulbright Specialist.
Kelley, an assistant professor of mechanical engineering, will travel to Canada in August to collaborate on academic curriculum development at the University of Windsor in Ontario, Florida Poly said in a news release. Kelley's research focuses on Parkinson's disease diagnosis and wearable care technology.
The Fulbright Specialist Program provides an opportunity for U.S. academics and established professionals to engage in project-based exchanges at host institutions around the world, the release said.
During Kelley's project at UWindsor, he will primarily collaborate with Jalal Ahamed, associate professor at UWindsor's Department of Mechanical, Automotive and Materials Engineering, in building mechatronics systems curriculum while incorporating biomedical aspects, the release said.
Mechatronics is an interdisciplinary field that combines mechanical engineering, electronics and computer systems to design and build intelligent, automated devices and processes, the release said.
'This is a really great opportunity, and I'm excited to be a part of it,' Kelley said in the release. 'Project-based learning engages students and helps them become better problem solvers because instead of doing everything on paper, they're physically working on something and accomplishing a goal.'
Kelley collaborated last year with Ahamed to develop sensors that capture changes in the gait of a person with Parkinson's disease. Ahamed was at Florida Poly as a Fulbright Canada research chair, the release said.
Kelley will conduct seminars, workshops and lectures on project-based and experiential learning. Upon his return, Kelley plans to begin implementing the new methods into Florida Poly's mechatronic systems, human robotics and other courses, the release said.
'Dr. Kelley's selection as a Fulbright Specialist highlights Florida Poly's growing role on the global stage,' said Mustapha Achoubane, the senior adviser for international relationships at Florida Poly. 'We are dedicated to fostering international partnerships and academic excellence that empower our faculty and students to become leaders and innovators in science and technology worldwide.'
This article originally appeared on The Ledger: Florida Poly assistant professor is named Fulbright Specialist
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
9 hours ago
- Newsweek
This New Test Could Diagnose Parkinson's With AI
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new artificial intelligence (AI) tool analyzing short smile videos achieved high accuracy in screening for Parkinson's disease (PD), according to research published by Tariq Adnan, and colleagues in the New England Journal of Medicine (NEJM) Thursday. The model was trained on the largest known video dataset of facial expressions to date, enrolling 1,452 participants, including 391 living with PD. An 87.9 percent overall accuracy in detecting PD using only smile video analysis, the NEJM AI study reported. Researchers reported that the AI model could accurately distinguish between individuals with and without PD based on the analysis of their smiles, even when applied in diverse population samples from North America and Bangladesh. Why It Matters The Parkinson's Foundation says an estimated 90,000 more people will be diagnosed this year, with the number of those suffering expected to be around 1.2 million by 2030. Diagnosing Parkinson's disease early remains a significant challenge because of limited access to clinical expertise and in-person evaluations. AI-driven remote screening tools promise scalable, cost-effective solutions to bridge these healthcare gaps. The findings align with the growing demand for digital healthcare solutions that remove geographical and economic barriers to early neurological disease diagnosis, which is especially relevant to rural and underserved American communities. What To Know The new screening method invited participants to record themselves mimicking facial expressions—including a smile—using an online platform. Research teams then extracted facial landmarks and measured action units to quantify hypomimia, a common motor symptom in PD where facial muscle movement is diminished. Machine learning models were developed using these features, distinguishing people with PD from those without. The approach relied on a broad recruitment strategy, involving participants from North America via social media, email, wellness centers, and research registries, alongside a high-risk cohort from Bangladesh. Trained solely on smile videos, the model achieved a 10-fold cross-validated accuracy of 87.9 percent, a sensitivity of 76.8 percent, and a specificity of 91.4 percent. Validation in external test sets revealed 80.3 percent accuracy in a U.S. clinic dataset and 85.3 percent accuracy in the Bangladesh cohort. While the negative predictive value remained above 92 percent in all settings, the positive predictive value dropped to 35.7 percent among the Bangladeshi participants, reflecting variations in population characteristics. The study found no significant differences in model performance across sex and ethnic subgroups, except for marginally higher accuracy in female participants in Bangladesh. The authors emphasized the generalizability and fairness of the approach, key considerations in the development of clinical AI tools. The video-processing and machine-learning code supporting the study is available to the public on GitHub. However, the study authors noted that raw video data sharing is restricted to comply with U.S. healthcare privacy law (HIPAA), limiting access to de-identified derivative features only. The research received funding from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, among other sources. The work was a collaborative effort involving academic and clinical partners such as the InMotion Parkinson's Disease wellness center and the University of Rochester Center for Health and Technology. The research process also benefited from contributions by staff at Google Research and the University of Rochester, particularly in statistical analysis. Stock image of brain MRI taken November 21, 2018. Stock image of brain MRI taken November 21, 2018. Getty What People Are Saying Tariq Adnan, lead author said in the study conclusion: "Smiling videos can effectively differentiate between individuals with and without PD, offering a potentially easy, accessible, and cost-efficient way to screen for PD, especially when access to clinical diagnosis is limited." What Happens Next? Future steps for the research team involve wider validation of the AI screening method in additional, real-world populations and further refinement of the algorithm to maximize early detection accuracy. Regulatory and clinical translation pathways will determine if and when this technology becomes available in the United States healthcare system.
Yahoo
2 days ago
- Yahoo
Sip your way to better health with the best green tea for 2025
Green tea has earned its worldwide rep as one of the healthiest beverages, and it's easy to see why. Packed with antioxidants and beneficial compounds like catechins and L-theanine, this mellow tea is linked to a whole host of health benefits. L-theanine, in particular, is known for smoothing out stress, sharpening focus and giving your mood a gentle lift. No wonder sipping on the best green tea has such a calming effect! But the magic of green tea doesn't stop at your brain. The compounds in green tea may also help combat inflammation, support heart health, balance blood sugar levels and even protect against chronic conditions like cancer, Alzheimer's disease, Parkinson's disease and type 2 diabetes. How, exactly? Green tea contains a mighty antioxidant called epigallocatechin-3-gallate (EGCG) that helps kick harmful free radicals to the curb. By tackling these unstable molecules, EGCG helps protect your cells from damage. With roots stretching back to ancient China, green tea has stood the test of time — and taste. Its light, grassy flavor and feel-good benefits keep tea drinkers coming back, steep after steep. But with so many green teas available — from loose-leaf to tea bags — it can be hard to know where to start. To help you find the best-tasting option, we heated up our kettle and brewed 20 different green teas, evaluating each on quality, aroma, bitterness, flavor and ease of steeping. We also teamed up with three registered dietitians, the founder of Dream Tea NYC and an herbalist to better understand what to look for in a high-quality green tea and the differences between various types. Whether you're after a bold flavor, organic ingredients or just something that's easy to brew, our ultimate green tea guide is here to help you choose. Best overall green tea More green teas we like Types of green tea Factors to consider How we chose Other green teas we tested FAQs Meet our experts Update, June 26, 2025: We checked all product prices and availability. Our No. 1 pick for best overall green tea, Upton Tea Imports Season's Pick China Sencha Organic Green Tea is out of stock and was replaced with our tester's runner-up favorite. (back to top) (back to top) There are many different types of green tea, and each has its own unique characteristics. Some of the most common types include Sencha, matcha, jasmine, Genmaicha, Dragonwell (Longjing), Gunpowder and flavored blends. We spoke with Adriana Ayales, an herbalist, medicine maker, educator and founder of Anima Mundi, to learn about the differences between varieties of green tea. Here's what she had to say: Sencha: This is a steamed green tea with a fresh, grassy profile. It's commonly enjoyed throughout Japan. Gyokuro: Known as the "dew of jewels," it is shaded before harvest, creating a tea rich in umami flavors and higher caffeine levels. Matcha: A ceremonial-grade powder that offers the most complete green tea experience, as the whole leaf is consumed. It provides antioxidants, vitamins and minerals that support energy and focus without the crash. Hojicha: Roasted green tea with a nutty flavor and lower caffeine — perfect for evening enjoyment. Bancha: A coarser green tea harvested later in the season, bringing mild flavors and minimal caffeine. Ayales notes that caffeine content can vary significantly between types of green tea. "Shade-grown teas like Gyokuro and matcha tend to have the highest caffeine levels, offering clean energy for the mind and body," she explains. In contrast, she notes that teas like Hojicha and Bancha have lower caffeine levels, making them gentler on the nervous system. (back to top) According to Anney Norton, founder of Dream Tea NYC, there are several factors to think about when choosing a green tea. These include: Tea origin: Norton's first recommendation is taking a peek at the country of origin, explaining, "Different countries have unique processing techniques that greatly impact the flavor profile of your green tea." For example, green tea from Japan (like Sencha and matcha) tends to be steamed, giving the tea more of a fresh or grassy flavor paired with a subtle sweetness. In contrast, green tea from China tends to be pan-fired, which gives it a nutty/smoky flavor with notes of caramel. Third-party certifications: Norton also recommends checking to see whether the tea is USDA organic and Fairtrade-certified. Why? "Unlike produce, which gets washed before consumption, we drink the liquid we soak our tea leaves in, and I would prefer to avoid any chemicals or pesticides in my morning cup!" she explains. She adds that Fairtrade is very important, as Fairtrade farms are more equitably compensated for their products. "This allows them to invest more money into their growing practices to produce a higher quality product and better care for their staff, as well as ensure sustainability throughout the supply chain," she explains. She adds that while Fairtrade comes at a higher price point, if you can afford it, it's worth the extra cost for the difference in product quality and the community-building, ethical benefits. Flavor: The flavor of your tea is determined by the type of green tea you select and whether it has additional ingredients, like flower petals, spices, herbs or dried fruit. "I tend to like green teas that are fruity or floral," says Norton, "so I will check for add-ins like orange, peach, rose or lavender." This allows you to find a green tea that is perfectly customized to your taste preferences. Loose leaf vs. bagged: As with all tea, green tea can be purchased in loose-leaf form or packaged in tea bags. While you'll need to invest in a steeper, loose leaf tea is often regarded as being higher quality. There are also some concerns about microplastics in certain tea bags. That said, some brands now package their tea using plastic-free materials, like hemp. (back to top) To choose the best green teas, we completed extensive hands-on testing. We sampled over 20 different green teas, rating them based on a range of criteria, including taste, aroma, ease of preparation and affordability. Each tea was sampled several times and brewed exactly to the individual teas' steeping instructions. This rigorous process enabled us to choose the best-tasting green teas that delivered both flavor and value for the money. Our research involved not only extensive testing but also garnering input from three registered dietitians, a tea entrepreneur from Dream Tea NYC and a herbalist in natural health. Plus, our tester (and writer) is also a registered dietitian and regular green tea drinker. Together, this combined expertise helped clarify what makes a green tea exceptional, from its nutritional value to its flavor profile. (back to top) We've been keeping our kettles busy testing lots of green teas, including 20 for this article and 12 matcha powders for another roundup. And then there's all the other types of teas we tried for various roundups, including 16 black teas, 13 teas for sleep, 11 teas for stress and anxiety and 70 teas for our ultimate tea roundup. Here are some of the other green teas we tried, including their pros and cons: Magic Hour Almond Matcha Green Tea for Joy: While we loved the sweet, nutty flavor of this tea, we docked it points for its too-sweet aftertaste. It also contains almonds, so it's unsuitable for people with a nut allergy. Magic Hour Goddess Green Tea: This tea had lovely sweet and floral notes. It did make our mouth feel slightly dry, but the main reason it didn't make our list is that we preferred Magic Hour's Emerald Green Tea as our favorite flavored green tea. Magic Hour Moonlight in Marrakesh: This tea had a pleasant minty and spicy flavor from peppermint, ginger and cinnamon. While it tasted nice, we felt that you could probably get a similar-tasting tea at a lower price point. Just Ice Tea Moroccan Mint: This lightly sweetened iced tea was refreshing, but it had a definite minty aftertaste that almost made you feel like you'd just brushed your teeth. Just Ice Tea Original Green Tea: This is the brand's unsweetened iced tea; to us, it tasted like a cup of tea we had forgotten about and let go cold. We don't need our teas to be super sweet, but a little hint of sweetness would help balance out the bitterness of the green tea here. Just Ice Tea Honey Green Tea: We really enjoyed the slightly sweet honey flavor of this iced tea. However, it had a slightly bitter aftertaste and tasted more like honey than green tea. NOW Organic Green Tranquility Decaf Green Tea with Lemon Myrtle: We really wanted to like this tea; a decaf green tea to sip on in the evening seemed right up our alley. However, the tea was so mild in flavor (even after steeping for longer than the suggested six minutes) that we couldn't really tell it was green tea. Plus, each bag was individually wrapped in plastic, which isn't great for the environment. Upton Tea Imports Korean Green Tea Jung-Jak Organic: This tea was pleasant to drink, with its grassy and fresh notes. It also wasn't bitter. However, other teas by this brand scored higher, so that's why this one didn't make the list. Upton Tea Imports Gyokuro Organic: This tea has a whopping 120 milligrams of caffeine, so it's definitely one you should try to drink earlier in the day. However, while it had nice umami and nutty flavors, it was one of the most expensive teas we sampled at about $0.60 per cup, and we felt there were other green teas that were better value for money. Upton Tea Imports Colombian Pan Fired: The Colombian Pan Fired green tea had a mild grassy flavor, but at $0.70 per cup, we felt there were more affordable options with better overall quality. Upton Tea Imports Lung Ching (Long Jing) Green (Superfine): This tea had a distinct grassy, slightly sweet flavor that made it a delightful sip. However, it was $0.51 per cup. We felt that the China Sencha green tea (at only $0.10 a cup) gives the same quality at a more affordable price point. Upton Tea Imports Special Grade Temple of Heaven Gunpowder Green: This green tea had a pleasant grassiness without being bitter. It was affordable, at $0.13 per cup. However, we felt there could have been a bit more "oomph" in flavor, and there were other similarly priced teas that we enjoyed more. Upton Tea Imports Young Hyson Imperial Organic: We steeped this tea for the recommended amount of time and could barely taste it. While it was one of the more affordable teas we reviewed, at $0.16 a cup, we wanted more flavor from our tea. Bigelow Green Tea with Ginger Plus Probiotics: This tea tasted more like ginger tea than green tea. We tried it over the span of a few days and didn't notice any changes in digestion. We would have preferred it if this tea tasted like green tea instead of ginger tea. (back to top) According to Alexia Zolis, founder of the Healthy Living RD, green tea is packed with antioxidants, particularly catechins, which help protect our cells from damage like oxidative stress — an imbalance between harmful free radicals and antioxidants — and inflammation. "These powerful compounds may also reduce the risk of certain types of cancer and chronic diseases like heart disease," she explains. Seema Shah, owner of Seema Shah Integrative and Functional Nutrition, adds that thanks to its L-theanine content, green tea may support and protect brain health, mood and memory. Plus, its rich content of anti-inflammatory phytochemicals like EGCG may also support heart and metabolic health. While many people tout green tea's weight loss benefits, Leah Reitmayer Murnane, owner of Lettuce Eat Dessert, explains the benefit may be overstated. "There is limited research about the popular claim that drinking green tea can support weight management." However, drinking green tea adds fluid to your diet without adding sugar from other liquids like soda, so it could aid with weight loss by simply reducing the total amount of sugar intake (and empty calories) you may be drinking from other beverages. "If you're a tea lover," says Zolis, "it can be easy to drink multiple cups of green tea every day." However, it's important to remember that green tea does still contain caffeine. Similar to other caffeinated drinks, if you drink too much, it may lead to symptoms like dehydration, restlessness or dizziness, says Zolis. "The recommended daily maximum amount of caffeine for adults to enjoy each day is 400 mg, according to the Food and Drug Administration. This translates to roughly eight to 10 cups of green tea per day. Everyone has different caffeine tolerance, so enjoying three to five cups is a safe and beneficial amount of green tea to have daily," says Zolis. However, keep in mind that this amount can still contain up to 225 milligrams of caffeine, says Reitmayer Murnane. "Brewing green tea is both an art and a ritual," says Ayales. "For loose leaf teas like Sencha, 170°F to 185°F is perfect," she explains, "as hotter water can scald the leaves, resulting in bitterness." For best results, steep the tea for one to three minutes to extract just the right amount of flavor and nutrients. When it comes to brewing matcha, the preparation is even more mindful, says Ayales. "Use warm water — around 158°F to 165°F — and whisk it into a vibrant froth with a bamboo whisk or hand frother," she explains. She adds that this method allows you to fully immerse yourself in the experience and connect with the vitality of the tea. "Drinking tea can become a daily practice of presence and gratitude," says Ayales, "deepening your connection to self and spirit." "Green tea contains less caffeine than coffee," says Zolis. "While a typical cup of coffee contains about 100 milligrams of caffeine, an 8-ounce cup of green tea typically contains between 30 and 50 milligrams of caffeine." However, the caffeine content of green tea can vary significantly depending on how long you brew it, with longer brewing times leading to a higher-caffeine cup of tea. Plus, matcha, where you consume the entire leaf, is higher in caffeine than loose-leaf green tea. "Green tea and matcha originate from the same plant," says Reitmayer Murnane, "but are processed and consumed differently." Green tea comes from leaves steeped in water and then discarded, while matcha is ground into a fine powder, allowing you to consume the whole leaf, she explains. "This results in matcha having high caffeine and antioxidant levels, along with a richer flavor and texture compared to a regular green tea," she adds. (back to top) Adriana Ayales, herbalist, medicine maker and founder of Anima Mundi Anney Norton, founder of Dream Tea NYC Alexia Zolis, RD and founder of the Healthy Living RD Leah Reitmayer Murnane, MS, RD, CSSD, LDN, owner of Lettuce Eat Dessert Seema Shah, RD, owner of Seema Shah Integrative and Functional Nutrition (back to top) Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.
Associated Press
2 days ago
- Associated Press
Novartis, BrainStorm Cell Therapeutics, Neuroplast, Rapa Therapeutics, and Longeveron Driving Innovations
DUBLIN--(BUSINESS WIRE)--Jun 27, 2025-- The 'Gene and Cell Therapies Targeting CNS Disorders Market - A Global and Regional Analysis: Focus on Drug and Region - Analysis and Forecast, 2025-2035" report has been added to offering. Global gene and cell therapies targeting central nervous system (CNS) disorders a market is on track for continued growth, driven by the aging population, and the development of more effective and comfortable solutions. The ongoing advancements in product technology and the expansion of care options will continue to shape the market's future. As demand for gene and cell therapies targeting central nervous system (CNS) disorders therapies rises, both global and regional players will play a key role in meeting the needs of individuals and healthcare systems alike, improving quality of life for people living with incontinence. The gene and cell therapies targeting central nervous system (CNS) disorders are rapidly advancing, offering potential treatments for conditions such as Parkinson's, Alzheimer's, Huntington's disease, and spinal cord injuries. Increasing incidences of CNS disorders one of the major driving factors of this market. The increasing number of patients with neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis is creating an urgent need for innovative treatments. This drives demand for gene and cell therapies, as current treatments are often ineffective or only offer temporary relief. One of the significant drivers of the global gene and cell therapies targeting central nervous system (CNS) disorders market is the technological advancements in treatment delivery. The technological innovations in drug delivery systems, such as CRISPR and gene editing, stem cell therapy and AAV vectors for gene delivery. Furthermore, improved precision in treatment technologies such as CRISPR-Cas9 allow for precise editing of genes involved in neurological diseases. This level of precision offers hope for conditions that have a genetic root, such as Huntington's disease or spinal muscular atrophy have contributed to the market's growth. Despite the growth trajectory, several challenges continue to impact the global gene and cell therapies targeting central nervous system (CNS) disorders market. One of the primary challenges is high development and manufacturing costs. The developing and manufacturing gene and cell therapies, especially those targeting CNS disorders, is extremely expensive. The production of viral vectors for gene delivery and the preparation of cell-based therapies are both costly and complex processes. The high costs of developing these therapies can limit accessibility and affordability for patients. Additionally, these high costs can result in delayed market entry and restrictions on patient access, particularly in low- and middle-income countries. Leading players in the global gene and cell therapies targeting central nervous system (CNS) disorders market, such as Novartis, and BrainStorm Cell Therapeutics are continuously innovating to improve the effectiveness and comfort of gene and cell therapies targeting central nervous system (CNS) disorders. These companies are investing heavily in research and development to introduce new, technologically advanced therapies into the market. With a strong emphasis on user-friendly and environmentally sustainable products, these companies are shaping the future of gene and cell therapies targeting central nervous system (CNS) disorders while enhancing their market positions globally. The competitive landscape of the global gene and cell therapies targeting central nervous system (CNS) disorders market is diverse, with numerous players across different regions offering a wide range of products. Regional players and local manufacturers are expected to play an important role in the market's growth, especially as demand increases in emerging markets such as Asia-Pacific. As consumer preferences shift towards more discreet, comfortable, and affordable solutions, the gene and cell therapies targeting central nervous system (CNS) disorders market will continue to evolve, fostering new opportunities for both established and emerging companies. As the gene and cell therapies targeting central nervous system (CNS) disorders market evolves, emerging trends such expansion of cell-based therapies and focuses on personalized or precision medicine. This trend allows treatments to be more specific and effective for individual patients, reducing side effects and improving patient outcomes. Companies Featured Key Topics Covered: Executive Summary 1. Global Gene and Cell Therapies Targeting CNS Disorders Market: Industry Outlook 1.1 Overview 1.2 Regulatory Landscape 1.3 Global Gene and Cell Therapies Targeting CNS Disorders Market, Patent Landscape 1.3.1 By Country 1.3.2 By Year 1.4 Global Gene and Cell Therapies Targeting CNS Disorders Market, Clinical Trials Landscape 1.5 Key Trends 1.6 Market Dynamics 1.6.1 Overview 1.6.1.1 Impact Analysis 1.6.2 Market Drivers 1.6.3 Market Restraints 1.6.4 Market Opportunities 2. Global Gene and Cell Therapies Targeting CNS Disorders Market, by Drugs, $Million, 2023-2035 2.1 Gene Therapy Drugs 2.2 Cell Therapy Drugs 3. Global Gene and Cell Therapies Targeting CNS Disorders, by Region, $Million, 2023-2035 3.1 North America 3.1.1 Key Findings in North America 3.1.2 Market Dynamics 3.1.3 Market Sizing and Forecast 3.1.3.1 North America Gene and Cell Therapies Targeting CNS Disorders Market, By Country 3.1.3.1.1 U.S. 3.1.3.1.2 Canada 3.2 Europe 3.2.1 Key Findings in Europe 3.2.2 Market Dynamics 3.2.3 Market Sizing and Forecast 3.2.3.1 Europe Gene and Cell Therapies Targeting CNS Disorders Market, By Country 3.2.3.1.1 Germany 3.2.3.1.2 U.K. 3.2.3.1.3 France 3.2.3.1.4 Italy 3.2.3.1.5 Spain 3.2.3.1.6 Rest-of-Europe 3.3 Asia-Pacific 3.3.1 Key Findings in Asia-Pacific 3.3.2 Market Dynamics 3.3.3 Market Sizing and Forecast 3.3.3.1 Asia-Pacific Gene and Cell Therapies Targeting CNS Disorders Market, By Country 3.3.3.1.1 Japan 3.3.3.1.2 China 3.3.3.1.3 India 3.3.3.1.4 Rest-of-Asia-Pacific 3.4 Rest-of-the-World 3.4.1 Key Findings in Rest-of-the-World 3.4.2 Market Dynamics 3.4.3 Market Sizing and Forecast 4. Global Gene and Cell Therapies Targeting CNS Disorders Market: Competitive Landscape and Company Profiles 4.1 Competitive Landscape 4.1.1 New Offerings 4.1.2 Mergers and Acquisitions 4.1.3 Partnerships, Alliances, and Business Expansion 4.1.4 Funding Activities 4.1.5 Regulatory Approvals 4.2 Company Profiles 4.2.1 Overview 4.2.2 Product Portfolio 4.2.3 Target Customers 4.2.4 Key Professionals 4.2.5 Analyst View 5. Research Methodology For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: GENERAL HEALTH NEUROLOGY HEALTH GENETICS PHARMACEUTICAL SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/27/2025 09:33 AM/DISC: 06/27/2025 09:33 AM
